Yumanity Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch YMTX and buy or sell other stocks, ETFs, and their options commission-free!About YMTX
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb.
CEOShawn P. Iadonato, PhD
CEOShawn P. Iadonato, PhD
Employees5
Employees5
HeadquartersMercer Island, Washington
HeadquartersMercer Island, Washington
Founded2008
Founded2008
Employees5
Employees5
YMTX Key Statistics
Market cap34.53M
Market cap34.53M
Price-Earnings ratio-0.50
Price-Earnings ratio-0.50
Dividend yield—
Dividend yield—
Average volume15.46K
Average volume15.46K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.15
52 Week high$1.15
52 Week low$0.1806
52 Week low$0.1806
Stock Snapshot
With a market cap of 34.53M, Yumanity Therapeutics(YMTX) trades at $2.55. The stock has a price-to-earnings ratio of -0.50.
Yumanity Therapeutics(YMTX) stock opened on 2025-12-29 at —. The price climbed to — and dipped to —.
Yumanity Therapeutics(YMTX) shares are trading with a volume of 0, against a daily average of 15.46K.
In the last year, Yumanity Therapeutics(YMTX) shares hit a 52-week high of $1.15 and a 52-week low of $0.18.
In the last year, Yumanity Therapeutics(YMTX) shares hit a 52-week high of $1.15 and a 52-week low of $0.18.
People also own
Based on the portfolios of people who own YMTX. This list is generated using Robinhood data, and it’s not a recommendation.